Allarity Therapeutics | Investor Conference Presentation Deck

Slide schematic 6/6

chart 2/2 list 1/1 source-note 1/1 title 2/2

Components 6

line line bullet source-note action-title headline

Tools 1

The slide presents a comparison of patient outcomes with and without Dovitinib-DRP, highlighting improved overall survival for patients with high DRP scores.

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 1

before-after-framing 90%

Contrasts the 'entire arm' (before/baseline) with the 'DRP positive' (after/intervention) to show efficacy.

Find anything

The slide demonstrates the predictive power of the DRP biomarker by contrasting the entire study population (no benefit) with the DRP-selected subgroup (significant benefit).